Carticept Medical's products are designed to address the shortcomings of current conservative
and surgical treatment options for osteoarthritis and cartilage injuries, as well as to provide
cost-effective and efficient solutions for the delivery of selected therapies.
ULTRASOUND EQUIPMENT
Carticept Medical distributes SonoSite ultrasound products to the
orthopedic marketplace.
SonoSite is the world leader in hand-carried ultrasound with small,
lightweight systems that are expanding the use of ultrasound across
the clinical spectrum by cost-effectively bringing high-performance
ultrasound to the point of patient care.
All products come with an industry-leading 5-year warranty.
|
|
NAVIGATOR ™ DS
The Company has developed the Navigator™ Delivery System
(Navigator DS), a computer-controlled, infusion system intended
to automate and improve the efficiency of fluid or medication
administration. Treatment data is provided in either a printed or
electronic format for the convenience of the user.
Through its core technologies and commitment to innovation,
Carticept will continue to advance novel therapies and to offer
cost-effective and efficient solutions that benefit both patients
and physicians.
|
|
CARTIVA ™ SCI
The Company’s first commercial product is the Cartiva™ Synthetic
Cartilage Implant (Cartiva SCI), designed to replace or repair worn
or damaged cartilage. The implant is made of an advanced proprietary
biomaterial with wear and other physical properties similar to human
cartilage. Cartiva SCI is currently available in Canada, Europe and
South America.
To date, several thousand patients have been implanted with Cartiva
SCI to address the pain and functional limitations associated with
osteoarthritis in a variety of joints including the knee, the first
metatarsophalangeal joint (great toe) and the carpometacarpal
joint (thumb).
* Cartiva SCI is approved for use in international markets, but is not
currently approved for sale or distribution in the United States.
|
|
|
|
